CCM
PTLA

Crabel Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Crabel Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-27,871
Closed -$501K – 64
2020
Q2 		$501K Buy
+27,871
New +$388K 2.15% 9

Crabel Capital Management's PTLA Position: Q3 2020 in Review

Crabel Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 27,871 shares — an estimated $501K sold.

Crabel Capital Management first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $501K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Crabel Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Crabel Capital Management sold 27,871 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $501K.
  • Crabel Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Crabel Capital Management's Portola Pharmaceuticals, Inc. position peaked at $501K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Crabel Capital Management's 13F filing for Q3 2020, filed 6 Nov 2020.